SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (8555)5/31/2003 3:46:13 PM
From: nigel bates  Respond to of 52153
 
Tyrosine kinases as targets in cancer therapy - successes and failures

Thanks, Eric. Tuck should like this -

...The identification and development of relevant target-directed biomarkers and diagnostic kits has to be initiated already at the beginning of a research programme. Consequently, it means integration of genomics, proteomics, imaging, biomarker and diagnostic kit development across the whole R&D process...